Company profile: Vascular Insights
1.1 - Company Overview
Company description
- Provider of medical devices for the minimally invasive treatment of peripheral vascular disease; engages in the design, development, manufacture and marketing of such devices and is the legal manufacturer of ClariVeinยฎ, a specialty infusion catheter with a rotating tip for controlled 360-degree dispersion of agents.
Products and services
๐
Key contacts
๐
๐
Financial details
๐
1.2 - Competitors and similar companies to Vascular Insights
CardioDynamics
HQ: United States
Website
- Description: Provider of noninvasive impedance cardiography diagnostic and monitoring devices and proprietary ICG sensors, including BioZ Dx, BioZ ICG Monitor, BioZ ICG Module, BioZtect sensors, Niccomo and Cardioscreen monitor, and Rheoscreen measurement devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full CardioDynamics company profile โ
Cardiol Therapeutics
HQ: Canada
Website
- Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Cardiol Therapeutics company profile โ
NeoChord
HQ: United States
Website
- Description: Provider of devices and services for mitral valve repair on a beating heart, including the NeoChord DS1000 System for echo-guided restoration of damaged mitral valve chords through a small incision; NeoChord ConsultConnect and ConnectCARD consultation services for delivery of artificial chordae tendineae to aid treatment of mitral insufficiency; and the Transcatheter Transseptal NeoChord NeXuS for MRI safety under specific conditions post-treatment with NeoChord devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full NeoChord company profile โ
Hyloris Pharmaceuticals
HQ: Belgium
Website
- Description: Provider of specialty pharmaceutical therapies, including Sotalol IV for atrial fibrillation (developed with AltaThera), Maxigesic IV, a non-opioid analgesic for post-operative pain combining paracetamol and ibuprofen sodium dihydrate (developed with AFT Pharmaceuticals), and Podofilox Gel 0.5% for anogenital warts, equivalent to Condylox.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Hyloris Pharmaceuticals company profile โ
Recovery Force
HQ: United States
Website
- Description: Provider of MORPH, an on-body pre recovery and performance enhancement system, developed and manufactured by Recovery Force.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Recovery Force company profile โ
๐
2.M&A buyers
2.1 Potential strategic acquirers in the sector
๐
๐
๐
๐
View all strategic buyers with complete profiles
Start Free Trial โ
2.2 - Strategic buyer groups for Vascular Insights
๐
Buyer group 1: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 2: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 3: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vascular Insights
2.2 - Growth funds investing in similar companies to Vascular Insights
๐
View all growth equity funds with complete profiles
Start Free Trial โ
4 - Top valuation comps for Vascular Insights
4.2 - Public trading comparable groups for Vascular Insights
๐ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ